Literature DB >> 27017174

Death after use of the synthetic cannabinoid 5F-AMB.

Kevin G Shanks1, George S Behonick2.   

Abstract

The use of synthetic cannabinoids and related products has been associated with adverse effects including seizure, acute kidney injury, and sudden death. We report the death of an individual that was associated with the synthetic cannabinoid 5F-AMB. Specimens were extracted via a liquid-liquid extraction at pH 10.2 into hexane:ethyl acetate. Analysis was completed via liquid chromatography tandem mass spectrometry. For this case report, we briefly describe the extraction and instrumental methods for 5F-AMB as well as the blood toxicology results (5F-AMB, 0.3ng/mL) and case circumstances and autopsy findings. Cause and manner of death was certified as accidental death due to synthetic cannabinoid toxicity. We also briefly review any previously published reports in which 5F-AMB was analytically confirmed and determined to be involved with cause of death.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  5F-AMB; Death; LC/MS/MS; Synthetic cannabinoid

Mesh:

Substances:

Year:  2016        PMID: 27017174     DOI: 10.1016/j.forsciint.2016.03.004

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  11 in total

1.  Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073.

Authors:  Ziva D Cooper; Justin L Poklis; Fei Liu
Journal:  Neuropharmacology       Date:  2017-11-14       Impact factor: 5.250

2.  Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic cannabinoids in rats.

Authors:  Michael B Gatch; Michael J Forster
Journal:  Psychopharmacology (Berl)       Date:  2017-11-14       Impact factor: 4.530

3.  Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors.

Authors:  Thomas F Gamage; Charlotte E Farquhar; Ryan J McKinnie; Richard C Kevin; Iain S McGregor; Mark L Trudell; Jenny L Wiley; Brian F Thomas
Journal:  J Pharmacol Exp Ther       Date:  2018-12-14       Impact factor: 4.030

Review 4.  The Role of Cannabinoids in CNS Development: Focus on Proliferation and Cell Death.

Authors:  Eduardo Cosendey Bockmann; Rafael Brito; Lucianne Fragel Madeira; Luzia da Silva Sampaio; Ricardo Augusto de Melo Reis; Guilherme Rapozeiro França; Karin da Costa Calaza
Journal:  Cell Mol Neurobiol       Date:  2022-08-04       Impact factor: 4.231

5.  Quantitation of Synthetic Cannabinoid Receptor Agonists in Postmortem Blood Using a Single Point Calibration.

Authors:  Phoebe Sharp; Simon Hudson; Stephen R Morley
Journal:  Acad Forensic Pathol       Date:  2021-07-20

6.  An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ.

Authors:  Paul L Morrow; Simon Stables; Kilak Kesha; Rexson Tse; Diana Kappatos; Rishi Pandey; Sarah Russell; Oliver Linsell; Mary Jane McCarthy; Amy Spark; Dianne Vertes; Yvonne Triggs; Sinead McCarthy; Nanise Cuthers; Richard Massey
Journal:  EClinicalMedicine       Date:  2020-07-24

7.  Optogenetic brain-stimulation reward: A new procedure to re-evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter-Cre mice.

Authors:  Bree A Humburg; Chloe J Jordan; Hai-Ying Zhang; Hui Shen; Xiao Han; Guo-Hua Bi; Briana Hempel; Ewa Galaj; Michael H Baumann; Zheng-Xiong Xi
Journal:  Addict Biol       Date:  2021-02-03       Impact factor: 4.093

8.  Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Roberta Tittarelli; Volker Auwärter; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2020-05-25       Impact factor: 4.157

Review 9.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

10.  Phenotype-Based Screening of Synthetic Cannabinoids in a Dravet Syndrome Zebrafish Model.

Authors:  Aliesha Griffin; Mana Anvar; Kyla Hamling; Scott C Baraban
Journal:  Front Pharmacol       Date:  2020-04-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.